Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystinosis | 3 | 2022 | 26 | 2.150 |
Why?
|
| Charcot-Marie-Tooth Disease | 6 | 2024 | 102 | 1.900 |
Why?
|
| Deglutition Disorders | 3 | 2022 | 640 | 1.090 |
Why?
|
| Psychometrics | 10 | 2023 | 3061 | 1.020 |
Why?
|
| Polyneuropathies | 3 | 2020 | 139 | 0.910 |
Why?
|
| Distal Myopathies | 2 | 2020 | 18 | 0.860 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 | 2020 | 36 | 0.850 |
Why?
|
| Andersen Syndrome | 1 | 2022 | 5 | 0.800 |
Why?
|
| Hypobetalipoproteinemias | 1 | 2022 | 11 | 0.800 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2023 | 116 | 0.750 |
Why?
|
| Malabsorption Syndromes | 1 | 2022 | 135 | 0.740 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2022 | 144 | 0.740 |
Why?
|
| Muscular Atrophy, Spinal | 2 | 2023 | 260 | 0.740 |
Why?
|
| Muscular Diseases | 3 | 2020 | 551 | 0.670 |
Why?
|
| Adrenoleukodystrophy | 4 | 2022 | 145 | 0.640 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 1 | 2018 | 17 | 0.600 |
Why?
|
| Neurophysiology | 1 | 2019 | 145 | 0.590 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2018 | 65 | 0.570 |
Why?
|
| Nerve Compression Syndromes | 1 | 2019 | 159 | 0.560 |
Why?
|
| Paresis | 1 | 2018 | 176 | 0.540 |
Why?
|
| Paintings | 1 | 2018 | 101 | 0.530 |
Why?
|
| Neuralgia | 2 | 2019 | 619 | 0.480 |
Why?
|
| Myasthenia Gravis | 2 | 2016 | 214 | 0.440 |
Why?
|
| Quality of Life | 10 | 2022 | 13463 | 0.430 |
Why?
|
| Severity of Illness Index | 9 | 2024 | 15878 | 0.420 |
Why?
|
| Family Health | 1 | 2018 | 1253 | 0.420 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2018 | 710 | 0.390 |
Why?
|
| Lower Extremity | 1 | 2019 | 1219 | 0.350 |
Why?
|
| Neuromuscular Diseases | 1 | 2011 | 260 | 0.320 |
Why?
|
| Neurologic Examination | 3 | 2020 | 913 | 0.280 |
Why?
|
| Sciatic Nerve | 2 | 2022 | 623 | 0.270 |
Why?
|
| Health Status Indicators | 1 | 2011 | 967 | 0.260 |
Why?
|
| Disability Evaluation | 4 | 2023 | 1820 | 0.220 |
Why?
|
| Barium | 1 | 2022 | 62 | 0.200 |
Why?
|
| Disease Progression | 5 | 2022 | 13614 | 0.190 |
Why?
|
| Primary Health Care | 1 | 2018 | 4736 | 0.180 |
Why?
|
| Deglutition | 1 | 2022 | 208 | 0.180 |
Why?
|
| Breathing Exercises | 1 | 2020 | 59 | 0.170 |
Why?
|
| Drugs, Investigational | 1 | 2022 | 211 | 0.170 |
Why?
|
| Adult | 24 | 2024 | 223088 | 0.160 |
Why?
|
| Respiratory Aspiration | 1 | 2020 | 89 | 0.160 |
Why?
|
| Activities of Daily Living | 2 | 2023 | 2414 | 0.160 |
Why?
|
| Tibial Nerve | 1 | 2019 | 55 | 0.160 |
Why?
|
| Lumbosacral Plexus | 1 | 2019 | 53 | 0.160 |
Why?
|
| Restless Legs Syndrome | 1 | 2022 | 236 | 0.160 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2022 | 497 | 0.150 |
Why?
|
| Hand Strength | 1 | 2020 | 462 | 0.140 |
Why?
|
| Urinary Tract | 1 | 2021 | 305 | 0.140 |
Why?
|
| Hashimoto Disease | 1 | 2018 | 108 | 0.140 |
Why?
|
| Humans | 34 | 2024 | 765926 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2019 | 412 | 0.130 |
Why?
|
| Botulinum Toxins | 1 | 2018 | 191 | 0.130 |
Why?
|
| Muscle Strength | 1 | 2020 | 638 | 0.130 |
Why?
|
| Mitochondrial Proteins | 2 | 2020 | 975 | 0.130 |
Why?
|
| Reproducibility of Results | 6 | 2023 | 20133 | 0.120 |
Why?
|
| Walking | 1 | 2023 | 1198 | 0.120 |
Why?
|
| Affect | 2 | 2013 | 1494 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1692 | 0.120 |
Why?
|
| Male | 25 | 2024 | 363815 | 0.120 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2014 | 43 | 0.120 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2018 | 552 | 0.120 |
Why?
|
| Encephalitis | 1 | 2018 | 440 | 0.120 |
Why?
|
| Diabetic Neuropathies | 1 | 2018 | 407 | 0.110 |
Why?
|
| Longitudinal Studies | 5 | 2022 | 14745 | 0.110 |
Why?
|
| Pedigree | 1 | 2022 | 4535 | 0.110 |
Why?
|
| Hand | 1 | 2019 | 908 | 0.110 |
Why?
|
| Extremities | 1 | 2019 | 868 | 0.110 |
Why?
|
| Medical History Taking | 1 | 2018 | 779 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 1086 | 0.100 |
Why?
|
| Cushing Syndrome | 1 | 2014 | 241 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2018 | 852 | 0.100 |
Why?
|
| Middle Aged | 17 | 2024 | 223016 | 0.100 |
Why?
|
| Sickness Impact Profile | 1 | 2013 | 297 | 0.100 |
Why?
|
| Retina | 2 | 2013 | 2648 | 0.100 |
Why?
|
| Brain Stem Neoplasms | 1 | 2014 | 192 | 0.100 |
Why?
|
| Fatigue | 1 | 2019 | 1553 | 0.100 |
Why?
|
| Young Adult | 9 | 2024 | 59857 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2022 | 8724 | 0.100 |
Why?
|
| Electric Stimulation Therapy | 1 | 2018 | 634 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2022 | 1657 | 0.090 |
Why?
|
| HIV Infections | 1 | 2018 | 17531 | 0.090 |
Why?
|
| Optic Neuritis | 1 | 2013 | 172 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5300 | 0.090 |
Why?
|
| Analgesics | 1 | 2018 | 1057 | 0.090 |
Why?
|
| Female | 22 | 2024 | 396141 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2018 | 2114 | 0.080 |
Why?
|
| Neuromyelitis Optica | 1 | 2013 | 266 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 1 | 2011 | 1607 | 0.080 |
Why?
|
| Nerve Fibers | 1 | 2013 | 703 | 0.080 |
Why?
|
| Mutation, Missense | 1 | 2018 | 2589 | 0.080 |
Why?
|
| Self Report | 1 | 2019 | 3768 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2020 | 3560 | 0.070 |
Why?
|
| Retrospective Studies | 8 | 2022 | 81537 | 0.070 |
Why?
|
| Phenotype | 2 | 2024 | 16714 | 0.070 |
Why?
|
| Retinal Ganglion Cells | 1 | 2013 | 811 | 0.070 |
Why?
|
| Aged | 12 | 2024 | 171163 | 0.070 |
Why?
|
| Perception | 1 | 2012 | 1204 | 0.060 |
Why?
|
| Employment | 1 | 2011 | 1107 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 12973 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 4959 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 8037 | 0.060 |
Why?
|
| Physicians | 1 | 2022 | 4591 | 0.060 |
Why?
|
| Myelin Proteins | 1 | 2024 | 212 | 0.050 |
Why?
|
| Age of Onset | 2 | 2020 | 3343 | 0.050 |
Why?
|
| Myelin P0 Protein | 1 | 2022 | 15 | 0.050 |
Why?
|
| Epilepsy | 1 | 2018 | 3317 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2013 | 2662 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2018 | 4746 | 0.050 |
Why?
|
| Peroxisomes | 1 | 2022 | 63 | 0.050 |
Why?
|
| Mutation | 2 | 2022 | 30192 | 0.040 |
Why?
|
| Wheelchairs | 1 | 2020 | 78 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2011 | 3136 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2013 | 2876 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2024 | 42510 | 0.040 |
Why?
|
| Orthotic Devices | 1 | 2020 | 131 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 36547 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2022 | 566 | 0.040 |
Why?
|
| Adolescent | 7 | 2024 | 88811 | 0.040 |
Why?
|
| Hyperalgesia | 1 | 2022 | 511 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2020 | 625 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2020 | 855 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3212 | 0.040 |
Why?
|
| Ion Channels | 1 | 2022 | 1044 | 0.040 |
Why?
|
| Child | 6 | 2024 | 80568 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2020 | 523 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 65194 | 0.030 |
Why?
|
| Gait | 1 | 2021 | 819 | 0.030 |
Why?
|
| Gadolinium | 1 | 2020 | 966 | 0.030 |
Why?
|
| Fourth Ventricle | 1 | 2014 | 32 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2020 | 2603 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2022 | 1804 | 0.030 |
Why?
|
| Prevalence | 2 | 2022 | 15828 | 0.030 |
Why?
|
| Postal Service | 1 | 2013 | 96 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 896 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 2120 | 0.030 |
Why?
|
| Patient Selection | 1 | 2024 | 4248 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 2744 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2021 | 54807 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2020 | 1949 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 2844 | 0.020 |
Why?
|
| Disabled Persons | 1 | 2019 | 1208 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4257 | 0.020 |
Why?
|
| United States | 2 | 2018 | 72909 | 0.020 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2013 | 550 | 0.020 |
Why?
|
| Atrophy | 1 | 2013 | 1629 | 0.020 |
Why?
|
| Bipolar Disorder | 1 | 2005 | 5128 | 0.020 |
Why?
|
| Pain | 1 | 2022 | 5077 | 0.020 |
Why?
|
| Contrast Media | 1 | 2020 | 5330 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 4555 | 0.020 |
Why?
|
| Infant | 2 | 2020 | 36426 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 14643 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2013 | 6321 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 59496 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2688 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2012 | 2020 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 18382 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 26282 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15401 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29890 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 40097 | 0.010 |
Why?
|
| Brain | 1 | 2005 | 27179 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41680 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2013 | 8060 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6202 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 81782 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 168735 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2005 | 6274 | 0.000 |
Why?
|
Concepts
(167)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_